BEGIN:VCALENDAR VERSION:2.0 CALSCALE:GREGORIAN PRODID:iCalendar-Ruby BEGIN:VEVENT CATEGORIES:Lectures & Presentations DESCRIPTION:Chemistry Colloquium: Dr. Milind Deshpande\, Jan. 31\n\nDr. Mil ind Deshpande will be the guest speaker for the Chemistry & Biochemistry Co lloquium: New Treatment Modalities for Small Molecule Therapeutics and Busi ness of Entrepreneurship: Incubation of Ideas and Company Creation. Dr. Des hpande is a Venture Partner at RA Capital\, and President & CEO of Nayan Th erapeutics\, a RA Capital portfolio company. Dr. Deshpande has more than 25 years of leadership and operational experience through all stages of drug discovery and development. He is the co-founder and Chairman of the Board o f Directors of Spero Therapeutics\, and past President\, CEO and member of the Board of Directors of Achillion Pharmaceuticals. Prior to joining Achil lion\, Dr. Deshpande was Group Leader at Bristol-Myers Squibb for all early -stage discovery programs in infectious diseases and neuroscience. He is th e co-inventor of first-in-class HCV NS5A inhibitors\, which led to the appr oval of Daklinza™\, the first marketed drug in its class. He received his d octorate in Organic Chemistry from Ohio University\, and was a Fellow and I nstructor in Department of Medicine\, Boston University School of Medicine DTEND:20240131T220500Z DTSTAMP:20241123T031128Z DTSTART:20240131T211000Z GEO:39.322732;-82.10287 LOCATION:Walter Hall\, 145 SEQUENCE:0 SUMMARY:Chemistry Colloquium: Dr. Milind Deshpande\, Jan. 31 UID:tag:localist.com\,2008:EventInstance_45145036304408 URL:https://calendar.ohio.edu/event/chemistry_colloquium_dr_milind_deshpand e END:VEVENT END:VCALENDAR